Hou MC - Search Results

1

Yen FS, Hou MC, Wei JC, Shih YH, Hsu CY, Hsu CC, Hwu CM. Yen FS, et al. Among authors: hou mc. Front Pharmacol. 2022 Dec 21;13:1049094. doi: 10.3389/fphar.2022.1049094. eCollection 2022. Front Pharmacol. 2022. PMID: 36618937 Free PMC article.

2

Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes.

Yen FS, Yang YC, Hwu CM, Wei JC, Huang YH, Hou MC, Hsu CC. Yen FS, et al. Among authors: hou mc. Liver Int. 2020 May;40(5):1089-1097. doi: 10.1111/liv.14385. Epub 2020 Feb 10. Liver Int. 2020. PMID: 31960563 Free PMC article.

3

Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.

Yen FS, Wei JC, Chiu LT, Hsu CC, Hou MC, Hwu CM. Yen FS, et al. Among authors: hou mc. Liver Int. 2021 Jan;41(1):110-122. doi: 10.1111/liv.14714. Epub 2020 Nov 11. Liver Int. 2021. PMID: 33124143

4

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.

Yen FS, Lai JN, Wei JC, Chiu LT, Hwu CM, Hou MC, Hsu CC. Yen FS, et al. Among authors: hou mc. PLoS One. 2020 Dec 14;15(12):e0243783. doi: 10.1371/journal.pone.0243783. eCollection 2020. PLoS One. 2020. PMID: 33315940 Free PMC article.

5

Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan.

Yen FS, Wei JC, Yip HT, Hwu CM, Hou MC, Hsu CC. Yen FS, et al. Among authors: hou mc. Hepatol Int. 2021 Feb;15(1):179-190. doi: 10.1007/s12072-020-10122-1. Epub 2021 Jan 10. Hepatol Int. 2021. PMID: 33423239

6

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?

Yen FS, Lai JN, Wei JC, Chiu LT, Hsu CC, Hou MC, Hwu CM. Yen FS, et al. Among authors: hou mc. BMC Gastroenterol. 2021 Jun 12;21(1):263. doi: 10.1186/s12876-021-01773-x. BMC Gastroenterol. 2021. PMID: 34118892 Free PMC article.

7

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Yen FS, Huang YH, Hou MC, Hwu CM, Lo YR, Shin SJ, Hsu CC. Yen FS, et al. Among authors: hou mc. Br J Clin Pharmacol. 2022 Jan;88(1):311-322. doi: 10.1111/bcp.14970. Epub 2021 Jul 22. Br J Clin Pharmacol. 2022. PMID: 34198358 Free PMC article.

8

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease.

Yen FS, Hsu CC, Wei JC, Hou MC, Hwu CM. Yen FS, et al. Among authors: hou mc. Front Med (Lausanne). 2022 Feb 16;9:839456. doi: 10.3389/fmed.2022.839456. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35252271 Free PMC article. Review.

9

The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver Injury.

Yen FS, Hou MC, Pan CW, Liu JS, Hsu CC, Hwu CM. Yen FS, et al. Among authors: hou mc. Diabetes Care. 2023 Jan 1;46(1):20-27. doi: 10.2337/dc22-1349. Diabetes Care. 2023. PMID: 36378550

10

Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes.

Yen FS, Hou MC, Liu JS, Hsu CC, Hwu CM. Yen FS, et al. Among authors: hou mc. Front Med (Lausanne). 2023 Jan 4;9:962337. doi: 10.3389/fmed.2022.962337. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters